Howard Leonhardt is an inventor and serial entrepreneur. He has 21 U.S. These include; cardiovascular balloon catheters, stent grafts for aneurysm repair, percutaneous heart valves, heart pacemakers with stem cell recruiting capabilities, electrical stimulation devices for promoting blood flow, electrical stimulation device for converting stem cells to heart muscle, stem cell compositions for heart repair, stem cell delivery systems, biological pacemakers and artificial lung catheter. patents for products for treating cardiovascular disease. His TALENT stent graft developed in the early 1990′s holds a leading world market share for repairing aortic aneurysms without surgery. His inventions have treated over 200,000 patients in 60 countries. In this Wall Street View, our host spoke with Howard Leonhardt, Founder, Chairman and CEO of Leonhardt Ventures at the Healthcare Media Day 2015 in San Francisco, CA.
Mr. Leonhardt discusses CRT Pacers, “Right now CRT Pacers, which is kind of the best technology for heart failure patients, they have leads that go to the healthy heart tissue. They don’t do anything to regenerate damaged heart tissue after a heart attack, the scar tissue, but they get the good tissue that surrounds the scar tissue to twitch just a little bit stronger than it would twitch without the electrical impulses. They’re reimbursed $58,000 per device, or per procedure, for implanting the CRT pacemakers.”
For more information, check out his website: www.LeonhardtVentures.com
© 2017 Stock News Now
Supported by Superior Web Solutions